Portal de Periódicos da CAPES

Low-FODMAP Diet for Irritable Bowel Syndrome: What We Know and What We Have Yet to Learn

2020; Annual Reviews; Volume: 71; Issue: 1 Linguagem: Inglês

10.1146/annurev-med-050218-013625

1545-326X

Jerry Liu, William D. Chey, Emily Haller, Shanti Eswaran,

Digestive system and related health

Irritable bowel syndrome (IBS) is the most prevalent of gastrointestinal (GI) conditions, affecting millions of people worldwide. Given that most IBS patients associate their GI symptoms with eating food, specific dietary manipulation has become an attractive treatment strategy. A diet low in FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) has generated the greatest level of scientific and clinical interest. Overall, 52–86% of patients report significant improvement of their IBS symptoms with elimination of dietary FODMAPs. Patients who experience symptom improvement with FODMAP elimination should undergo a structured reintroduction of foods containing individual FODMAPs to determine sensitivities and allow for personalization of the diet plan. This review discusses the literature surrounding the administration of the low-FODMAP diet and its efficacy in the treatment of IBS.